Flagship Harbor Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-559
| Closed | -$81K | – | 597 |
|
|
2020
Q3 | $81K | Hold |
559
| – | – | 0.01% | 710 |
|
|
2020
Q2 | $82K | Buy |
559
+15
| +3% | +$2.2K | 0.01% | 708 |
|
|
2020
Q1 | $59K | Hold |
544
| – | – | 0.01% | 705 |
|
|
2019
Q4 | $63K | Buy |
544
+33
| +6% | +$3.82K | 0.01% | 744 |
|
|
2019
Q3 | $41K | Hold |
511
| – | – | 0.01% | 831 |
|
|
2019
Q2 | $37K | Hold |
511
| – | – | 0.01% | 851 |
|
|
2019
Q1 | $47K | Buy |
+511
| New | +$47K | 0.01% | 768 |
|